La cadena de opciones muestra datos clave de las opciones de acciones de Gossamer Bio a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Gossamer Bio..

Gossamer Bio (NASDAQ:GOSS) Bolsa, Cadena de Opciones

GOSSAMER BIO INC

Gossamer Bio

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Gossamer Bio Inc

GOSSAN RESOURCES LTD CDA by Gossan Resources Ltd.

Gossan Resources Ltd

Seagate Tech Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>) has outperformed the market over the past 15 years by 5.13% on an annualized basis producing an average annual return of 17.58%. Currently, Seagate Tech Hldgs has a market capitalization of $31.08 billion. 
Buying $100 In STX: If an investor had bought $100 of STX stock 15 years ago, it would be worth $1,025.81 today based on a price of $146.80 for STX at the time of writing.
<h3>Seagate Tech Hldgs's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752618611_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

Here's How Much $100 Invested In Seagate Tech Hldgs 15 Years Ago Would Be Worth Today

Billionaire Tim Draper has revealed some new lore about "the first family of Silicon Valley."
In a proud dad moment, Draper <a href="https://x.com/TimDraper/status/1942614766494834990?t=8Kh0lZ2bEcBvEtkPBwCmVw&amp;s=19">said</a> Tuesday on X that son Adam Draper beat him to "the best investment of the decade."
The investment in question is leading cryptocurrency exchange Coinbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), a venture known to have been backed by the father and son.
Draper said he had missed out on the company&#8217;s seed round due to a conflict of interest, but his son, having no such constraints, had dived in after an impressive pitch from Coinbase CEO Brian Armstrong.&nbsp;
Don't Miss:
<ul class="wp-block-list">
<li>Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a></li>
<li>$100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.</li>
</ul>
"We love the pitch and love Brian," Draper said. "I want in immediately, but I&#8217;d already invested in CoinLab (a startup with a similar premise). So… I passed on the seed round. Oops. My son didn&#8217;t have that conflict and invested in Coinbase&#8217;s first round at a very good price."
Draper said he was later able to get in during the firm&#8217;s growth round and the pre-IPO, but stressed that his son&#8217;s returns far outweighed his own.
"Both were great successes, but my son's returns solidly beat my own," he said. "Good to see that each generation gets better than the one before."
Trending: This AI-Powered Trading Platform Has 5,000+ Users, 27 Pending Patents, and a $43.97M Valuation — <a href="https://www.benzinga.com/money/finally-a-fully-automated-trading-platform-for-individual-investors?">You Can Become an Investor for Just $500.25</a>
<h2 class="wp-block-heading">A Family Affair</h2>
For the Draper family, venture capital is a family affair. Draper himself is a third generation venture capitalist, who made his first venture capital investments in the ‘80s following in the footsteps of his father William Henry Draper III, who himself got into the business in the ‘50s following in the footsteps of William Henry Draper Jr. who founded the VC firm Draper, Gaither and Anderson.
Like Draper, most of his children have followed the venture capital path. Draper&#8217;s first son, Adam, founded Boost VC in 2012, an early-stage venture capital firm focusing on Bitcoin businesses.
Commenting on his father&#8217;s account of his Coinbase investment, Adam <a href="https://x.com/AdamDraper/status/1942642673493426469?t=-XsD8OxXQgihAS9Sevr9_g&amp;s=19">said</a> the investment "defined" his career.
"The network I built from this one investment is priceless," he said. "The obsession with the Bitcoin rebellion is priceless. The understanding of how markets evolve is also priceless."
See Also: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
He quoted Armstrong as saying at the time that "at some point the world will be on one financial infrastructure," adding, "this could be a trillion dollar opportunity."
According to the fourth-generation venture capitalist, however, in hindsight, Armstrong was wrong.
"He was wrong," he said. "The crypto space is already multiples of trillions."
To be sure, the cryptocurrency space has come a long way from its niche libertarian roots. At last look, the market boasts a market capitalization of nearly $3.7 trillion as the adoption of Bitcoin and the underlying blockchain technology grows on <a href="https://www.benzinga.com/crypto/25/07/46261889/bitcoins-fourth-of-july-journey-from-revolutionary-vision-to-wall-streets-darling">Wall Street</a>.&nbsp;
Coinbase, now the largest cryptocurrency exchange by volume in the U.S., has been a key player in the industry&#8217;s rise and <a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45416971/coinbase-becomes-first-pure-play-crypto-stock-in-sp-500-analyst-sees-major-institutional-upside">recently became</a> the first cryptocurrency native firm to be included in the S&amp;P 500. At last look, the firm boasts a market capitalization of $99 billion.
Read Next: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
Image: Shutterstock

Personal Finance

COIN

Billionaire Tim Draper Says His Son Beat Him To 'The Best Investment Of The Decade': 'My Son's Returns Solidly Beat My Own'

KKR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) has outperformed the market over the past 5 years by 17.5% on an annualized basis producing an average annual return of 31.41%. Currently, KKR has a market capitalization of $124.21 billion. 
Buying $100 In KKR: If an investor had bought $100 of KKR stock 5 years ago, it would be worth $392.25 today based on a price of $139.46 for KKR at the time of writing.
<h3>KKR's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752617714_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In KKR 5 Years Ago Would Be Worth Today

BitMine Immersion Technologies Inc (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BMNR#AMEX">BMNR</a>) shares are ripping higher in Tuesday&#8217;s after-hours session after billionaire PayPal and Palantir co-founder Peter Thiel disclosed a stake <a href="https://www.benzinga.com/m-a/25/07/46432052/bitmine-immersion-technologies-13d-filing-shows-peter-thiel-linked-ff-consumer-growth-discloses-9-1">in the company</a>.
What To Know: Thiel&#8217;s Founders Fund Growth II Management disclosed in an SEC filing late Tuesday that it took a 9.1% stake in BitMine Immersion Technologies as of July 8. 
BitMine recently announced a pivot to an Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) treasury strategy, which has sparked a flurry of buying in the name.
BitMine closed on an initial private placement of $250 million last week with intentions to accumulate ETH, the native cryptocurrency of the Ethereum blockchain. The company announced on Monday that it&#8217;s now holding a total of 163,142 ETH. 
Before announcing the Ethereum treasury strategy, BitMine had a market cap of just $25.86 million and shares had fallen around 45% since the start of the year.&nbsp;BitMine&#8217;s market cap was up to approximately $2.12 billion as of Tuesday&#8217;s close, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
A lot of the attention came after Fundstrat&#8217;s&nbsp;Tom Lee&nbsp;was appointed chairman of the company&#8217;s board. Lee has discussed the company&#8217;s strategy in several television interviews since, which has sparked significant investor interest in multiple companies that recently adopted ETH strategies.
GameSquare Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAME#NASDAQ">GAME</a>) announced an Ethereum treasury strategy last week. The stock has been trending higher since the announcement. The company on Tuesday scheduled a conference call to review its Ethereum strategy, which sent shares up more than 25% in extended trading.
Other companies to announce Ethereum treasury strategies this year include SharpLink Gaming, Bit Digital and BTCS Inc.
BMNR Price Action: <a href="http://benzinga.com/quote/BMNR">BitMine shares</a> were up 15.47% in after-hours, trading at $46.14 at the time of publication on Tuesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
 • <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46429234/bitcoin-xrp-dogecoin-dip-but-ethereum-outperforms-after-inflation-report">Bitcoin, XRP, Dogecoin Dip But Ethereum Outperforms After Inflation Report</a>
Photo: VPLAB/Shutterstock.com

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

After-Hours Center

Movers

Tech

$ETH

BMNR

GAME

BitMine Immersion Technologies Stock Surges After Hours: What's Going On?

Park-Ohio Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PKOH#NASDAQ">PKOH</a>) sees Q2 sales of $400.000 million-$410.000 million vs $416.000 million analyst estimate.

Guidance

PKOH

Park-Ohio Hldgs Sees Q2 Sales $400.000M-$410.000M vs $416.000M Est

<a href="https://www.theinformation.com/articles/openai-preps-chatgpt-agents-challenge-microsoft-excel-powerpoint">https://www.theinformation.com/articles/openai-preps-chatgpt-agents-challenge-microsoft-excel-powerpoint</a>

General

MSFT

'OpenAI Preps ChatGPT Agents in Challenge to Microsoft Excel and PowerPoint'- The Information

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares fell in Tuesday trading as the market reacted to executive instability and mounting pressure on its autonomous driving ambitions. Here&#8217;s what investors <a href="https://www.benzinga.com/quote/TSLA/news">need to know</a>.
What To Know: The latest blow came with news of the departure of Troy Jones, the company&#8217;s vice president of sales for North America and a 15-year veteran. His exit marks another <a href="https://www.benzinga.com/markets/large-cap/25/07/46426351/teslas-sales-turmoil-deepens-with-north-america-sales-chiefs-exit">significant leadership change</a>, following top Elon Musk aide Omead Afshar last month, and comes amidst what has been described as &#8220;sales turmoil&#8221; for the electric vehicle giant.
Adding to investor concerns, a nominee to lead the U.S. National Highway Traffic Safety Administration (NHTSA) stated in written testimony that regulators &#8220;cannot sit back and wait for problems to arise&#8221; with self-driving cars, signaling a potentially tougher oversight environment. This scrutiny follows a string of negative headlines for Tesla's <a href="https://www.benzinga.com/topic/fsd">Full Self-Driving (FSD)</a> technology.
The company was recently forced in arbitration to <a href="https://www.benzinga.com/markets/tech/25/07/46290586/elon-musks-tesla-forced-to-pay-nearly-18000-in-model-y-fsd-arbitration-full-self-driving-was-nowhere-near-autonomous">pay nearly $18,000</a> to a customer after its FSD was deemed &#8220;nowhere near autonomous.&#8221; This legal setback compounds ongoing probes into traffic violations by its robotaxis in Austin. 
Despite these challenges, CEO Elon Musk <a href="https://www.benzinga.com/markets/tech/25/07/46337340/elon-musk-says-tesla-will-expand-robotaxi-services-to-san-francisco-bay-area-in-a-month-or-two">recently announced</a> plans to expand the robotaxi service to the San Francisco Bay Area within &#8220;a month or two.&#8221;
Tesla is meanwhile scheduled to announce its latest quarterly financial results after the market closes on Wednesday, July 23. For the quarter, Wall Street <a href="https://www.benzinga.com/quote/TSLA/earnings">analysts</a> are forecasting EPS of 42.3 cents on total revenue of $22.79 billion. 
Benzinga Edge Rankings: Based on <a href="http://benzinga.grsm.io/register174">Benzinga Edge</a> stock rankings, Tesla exhibits the profile of a classic high-growth investment trading at a premium. The company scores exceptionally high for Growth at 90.93, indicating strong forward-looking expansion potential. 
However, it receives a very low Value score of 10.39, suggesting that its current stock price is considered expensive relative to its fundamental financial metrics. Tesla&#8217;s other ratings are neutral, with a middling Momentum score of 45.01 and a Quality score of 49.98, indicating average marks for its recent price trends and overall financial health.
TSLA Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, Tesla shares closed Tuesday&#8217;s session lower by 1.93% to $310.78. The stock has a 52-week high of $488.54 and a 52-week low of $182.
Read Also: <a href="https://www.benzinga.com/markets/tech/25/07/46268433/teslas-full-self-driving-tech-under-fire-again-after-robotaxi-nearly-hits-parked-vehicle-report">Tesla&#8217;s Full Self-Driving Tech Under Fire Again After Robotaxi Nearly Hits Parked Vehicle: Report</a>
<h2 class="wp-block-heading">How To Buy TSLA Stock</h2>
By now, you're likely curious about how to participate in the market for Tesla — be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Tesla, which was trading at $310.78 as of when this article was written, $100 would buy you 0.32 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option or sell a call option at a strike price above where shares are currently trading; either way, it allows you to profit from the share price decline.
Image: Courtesy of Tesla

Management

TSLA

Tesla Stock Slides Amid Executive Departure, Intensifying Scrutiny On Self-Driving Tech

Across the recent three months, 4 analysts have shared their insights on Tradeweb Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TW#NASDAQ">TW</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Tradeweb Markets and provided 12-month price targets. The average target is $146.75, accompanied by a high estimate of $159.00 and a low estimate of $130.00. Surpassing the previous average price target of $144.00, the current average has increased by 1.91%.
<img src="https://www.benzinga.com/files/images/story/2025/1752616859_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A comprehensive examination of how financial experts perceive Tradeweb Markets is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Patrick Moley</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$130.00</td>
<td>$127.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$152.00</td>
<td>$159.00</td>
</tr>
<tr>
<td>Kenneth Worthington</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$146.00</td>
<td>$137.00</td>
</tr>
<tr>
<td>Bill Katz</td>
<td>TD Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$159.00</td>
<td>$153.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Tradeweb Markets. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Tradeweb Markets compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Tradeweb Markets's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/TW/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Tradeweb Markets analyst ratings.</a>
<h2>Get to Know Tradeweb Markets Better</h2>
Founded in 1998 and headquartered in New York City, Tradeweb Markets is a leading fixed-income trading platform. While it does offer electronic processing for some voice-negotiated trades, the company focuses primarily on providing electronic trading networks that connect broker/dealers, institutional clients, and retail customers. While the company offers trading in a wide variety of products, the bulk of its business is in U.S. and European government debt, mortgage-backed securities, interest-rate swaps, and U.S. and international corporate bonds. The firm also sells fixed-income trading and price data, primarily through a deal with Refinitiv's Eikon service.
<h3>Tradeweb Markets's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Tradeweb Markets's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 24.7% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 29.09%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Tradeweb Markets's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.53% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Tradeweb Markets's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.03%, the company showcases efficient use of assets and strong financial health.
Debt Management: Tradeweb Markets's debt-to-equity ratio is below the industry average at 0.01, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: What Are They?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Assessing Tradeweb Markets: Insights From 4 Financial Analysts

Providing a diverse range of perspectives from bullish to bearish, 9 analysts have published ratings on Citigroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) in the last three months.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Citigroup and provided 12-month price targets. The average target is $92.33, accompanied by a high estimate of $103.00 and a low estimate of $77.00. Marking an increase of 7.5%, the current average surpasses the previous average price target of $85.89. 
<img src="https://www.benzinga.com/files/images/story/2025/1752616850_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Citigroup. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Erika Najarian</td>
<td>UBS</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$89.00</td>
<td>$89.00</td>
</tr>
<tr>
<td>John McDonald</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$93.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Betsy Graseck</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$103.00</td>
<td>$94.00</td>
</tr>
<tr>
<td>Richard Ramsden</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$96.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Glenn Schorr</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$77.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Ebrahim Poonawala</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$100.00</td>
<td>$89.00</td>
</tr>
<tr>
<td>Betsy Graseck</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$94.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Richard Ramsden</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$85.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Chris Kotowski</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$94.00</td>
<td>$91.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Citigroup. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Citigroup compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
To gain a panoramic view of Citigroup's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/C/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Citigroup analyst ratings.</a>
<h2>Unveiling the Story Behind Citigroup</h2>
Citigroup is a global financial-services company doing business in more than 100 countries and jurisdictions. Citigroup's operations are organized into five primary segments: services, markets, banking, US personal banking, and wealth management. The bank's primary services include cross-border banking needs for multinational corporates, investment banking and trading, and credit card services in the United States.
<h3>Understanding the Numbers: Citigroup's Finances</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Revenue Growth: Citigroup's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 2.83%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Citigroup's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 17.36%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Citigroup's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 1.95%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.15%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Citigroup's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.78, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: Citigroup Through The Eyes Of 9 Analysts

During the last three months, 4 analysts shared their evaluations of Olaplex Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLPX#NASDAQ">OLPX</a>), revealing diverse outlooks from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $1.73, a high estimate of $2.00, and a low estimate of $1.40. This upward trend is evident, with the current average reflecting a 4.85% increase from the previous average price target of $1.65.
<img src="https://www.benzinga.com/files/images/story/2025/1752616841_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Olaplex Hldgs among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$1.50</td>
<td>$1.40</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$1.40</td>
<td>$1.20</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$2.00</td>
<td>$2.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$2.00</td>
<td>$2.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Olaplex Hldgs. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Olaplex Hldgs compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
For valuable insights into Olaplex Hldgs's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/OLPX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Olaplex Hldgs analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Get to Know Olaplex Hldgs Better</h2>
Olaplex Holdings Inc is a science-enabled, technology-driven beauty company. It offers science-backed solutions that improve hair health. It identifies the majority of consumers' relevant haircare concerns in collaboration with the community of professional hairstylists and consumers and strives to address them through its proprietary technology and innovation capabilities. It offers products through an omnichannel platform that serves professional, specialty retail, and DTC channels. The company derives its revenue through the sale of its hair care products. The company generates the majority of revenue from Professional sales channels followed by Specialty Retail and then DTC. Geographically the company generates the majority of its revenue from the International market.
<h3>A Deep Dive into Olaplex Hldgs's Financials</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Challenges: Olaplex Hldgs's revenue growth over 3M faced difficulties. As of 31 March, 2025, the company experienced a decline of approximately -1.95%. This indicates a decrease in top-line earnings. When compared to others in the Consumer Staples sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Olaplex Hldgs's net margin excels beyond industry benchmarks, reaching 0.48%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Olaplex Hldgs's ROE excels beyond industry benchmarks, reaching 0.05%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Olaplex Hldgs's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.03% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.74.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

OLPX

What Analysts Are Saying About Olaplex Hldgs Stock

In the latest quarter, 4 analysts provided ratings for Equity Lifestyle Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELS#NYSE">ELS</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $71.38, a high estimate of $77.00, and a low estimate of $67.50. This current average represents a 4.83% decrease from the previous average price target of $75.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1752616834_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Equity Lifestyle Props. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Adam Kramer</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$67.50</td>
<td>-</td>
</tr>
<tr>
<td>Anthony Powell</td>
<td>Barclays</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$70.00</td>
<td>-</td>
</tr>
<tr>
<td>Anthony Hau</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$71.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Juan Sanabria</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$77.00</td>
<td>$78.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Equity Lifestyle Props. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Equity Lifestyle Props compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Equity Lifestyle Props's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into Equity Lifestyle Props's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/ELS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Equity Lifestyle Props analyst ratings.</a>
<h2>About Equity Lifestyle Props</h2>
Equity Lifestyle Properties is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company currently has a portfolio of 455 properties across the U.S. with a higher concentration in the Sunbelt region with 38% of the company's properties located in Florida, 12% in Arizona, and 8% in California. Equity Lifestyle targets owning properties in attractive retirement destinations with over 70% of the company's properties either being age-restricted or having an average resident age over 55.
<h3>Understanding the Numbers: Equity Lifestyle Props's Finances</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: Equity Lifestyle Props's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 0.19%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Real Estate sector.
Net Margin: Equity Lifestyle Props's net margin excels beyond industry benchmarks, reaching 29.71%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Equity Lifestyle Props's ROE stands out, surpassing industry averages. With an impressive ROE of 6.26%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Equity Lifestyle Props's ROA stands out, surpassing industry averages. With an impressive ROA of 1.93%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Equity Lifestyle Props's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.81, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>What Are Analyst Ratings?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About Equity Lifestyle Props Stock

During the last three months, 8 analysts shared their evaluations of Reynolds Consumer Prods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REYN#NASDAQ">REYN</a>), revealing diverse outlooks from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Reynolds Consumer Prods, revealing an average target of $26.25, a high estimate of $30.00, and a low estimate of $21.00. This current average has decreased by 8.28% from the previous average price target of $28.62. 
<img src="https://www.benzinga.com/files/images/story/2025/1752616827_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
A comprehensive examination of how financial experts perceive Reynolds Consumer Prods is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$21.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Brian McNamara</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Hold</td>
<td>$26.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$25.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$25.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$30.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Bill Chappell</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$30.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Brian McNamara</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Hold</td>
<td>$27.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$26.00</td>
<td>$29.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Reynolds Consumer Prods. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Reynolds Consumer Prods compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Reynolds Consumer Prods's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Reynolds Consumer Prods's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/REYN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Reynolds Consumer Prods analyst ratings.</a>
<h2>Unveiling the Story Behind Reynolds Consumer Prods</h2>
Reynolds Consumer Products Inc is a provider of household products. The firm is engaged in the production and sales of cooking products, waste and storage products, and tableware. It operates through four reportable segments namely, Reynolds Cooking and Baking, Hefty Waste and Storage, Hefty Tableware, and Presto Products. Reynolds Cooking and Baking segment produce branded and store brand aluminum foil, disposable aluminum pans, parchment paper, freezer paper, wax paper, butcher paper, plastic wrap, baking cups, oven bags and slow cooker liners.
<h3>Financial Milestones: Reynolds Consumer Prods's Journey</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Negative Revenue Trend: Examining Reynolds Consumer Prods's financials over 3M reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately -1.8% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Staples sector.
Net Margin: Reynolds Consumer Prods's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 3.79%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Reynolds Consumer Prods's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 1.45%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Reynolds Consumer Prods's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.64%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Reynolds Consumer Prods's debt-to-equity ratio is below the industry average. With a ratio of 0.82, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Basics of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

REYN

Analyst Expectations For Reynolds Consumer Prods's Future

Throughout the last three months, 4 analysts have evaluated Globus Medical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMED#NYSE">GMED</a>), offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Globus Medical and provided 12-month price targets. The average target is $73.25, accompanied by a high estimate of $80.00 and a low estimate of $68.00. A 14.58% drop is evident in the current average compared to the previous average price target of $85.75. 
<img src="https://www.benzinga.com/files/images/story/2025/1752616818_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The standing of Globus Medical among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Drew Ranieri</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$68.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Richard Newitter</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$68.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Ryan Zimmerman</td>
<td>BTIG</td>
<td>Lowers</td>
<td>Buy</td>
<td>$77.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Matt O'Brien</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$80.00</td>
<td>$100.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Globus Medical. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Globus Medical compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Globus Medical's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Globus Medical's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/GMED/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Globus Medical analyst ratings.</a>
<h2>All You Need to Know About Globus Medical</h2>
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
<h3>Globus Medical's Economic Impact: An Analysis</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Negative Revenue Trend: Examining Globus Medical's financials over 3M reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately -1.41% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.
Net Margin: Globus Medical's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 12.62%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Globus Medical's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 1.83%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Globus Medical's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.51% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a below-average debt-to-equity ratio of 0.02, Globus Medical adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>How Are Analyst Ratings Determined?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GMED

4 Analysts Assess Globus Medical: What You Need To Know

Looking into the current session, Kyndryl Hldgs Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KD#NYSE">KD</a>) shares are trading at $39.11, after a 1.16% decrease. Over the past month, the stock decreased by 2.73%, but over the past year, it actually spiked by 44.98%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1752616817_0.png" alt="Past Year Chart" />

<h3>How Does Kyndryl Hldgs P/E Compare to Other Companies?</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Kyndryl Hldgs has a lower P/E than the aggregate P/E of 63.83 of the IT Services industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1752616817_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

A Look Into Kyndryl Hldgs Inc's Price Over Earnings

Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>) has outperformed the market over the past 10 years by 1.15% on an annualized basis producing an average annual return of 12.53%. Currently, Aflac has a market capitalization of $54.59 billion. 
Buying $1000 In AFL: If an investor had bought $1000 of AFL stock 10 years ago, it would be worth $3,269.01 today based on a price of $100.62 for AFL at the time of writing.
<h3>Aflac's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752616815_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today

<a href="https://www.wsj.com/finance/investing/trump-executive-order-to-help-open-up-401-k-s-to-private-markets-c90c6788">https://www.wsj.com/finance/investing/trump-executive-order-to-help-open-up-401-k-s-to-private-markets-c90c6788</a>

'Trump Executive Order to Help Open Up 401(k)s to Private Markets'- WSJ

FingerMotion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNGR#NASDAQ">FNGR</a>) reported quarterly losses of $(0.04) per share. This is a 33.33 percent decrease over losses of $(0.03) per share from the same period last year. The company reported $8.459 million in sales this quarter. This is a 1.02 percent increase over sales of $8.374 million the same period last year.

Earnings

FNGR

FingerMotion Q1 EPS $(0.04) Down From $(0.03) YoY, Sales $8.459M Up From $8.374M YoY

NextTrip (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRP#NASDAQ">NTRP</a>) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0.08) by 750 percent. This is a 55.84 percent increase over losses of $(1.54) per share from the same period last year. The company reported quarterly sales of $138.827 thousand which missed the analyst consensus estimate of $1.495 million by 90.71 percent. This is a 26.47 percent decrease over sales of $188.793 thousand the same period last year.

Earnings Misses

NTRP

NextTrip Q1 EPS $(0.68) Misses $(0.08) Estimate, Sales $138.827K Miss $1.495M Estimate

Hancock Whitney (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWC#NASDAQ">HWC</a>) reported quarterly earnings of $1.37 per share which beat the analyst consensus estimate of $1.36 by 0.96 percent. This is a 4.58 percent increase over earnings of $1.31 per share from the same period last year. The company reported quarterly sales of $378.000 million which beat the analyst consensus estimate of $376.072 million by 0.51 percent. This is a 5.12 percent increase over sales of $359.604 million the same period last year.

Earnings Beats

CORRECTION: Hancock Whitney Q2 Adj. EPS $1.37 Beats $1.36 Estimate, Sales $378.000M Beat $376.072M Estimate

SAULT STE. MARIE, Ontario, July 15, 2025 (GLOBE NEWSWIRE) -- Algoma Steel Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTL#NASDAQ">ASTL</a>, TSX:<a class="ticker" href="https://www.benzinga.com/stock/ASTL#TSX">ASTL</a>) ("Algoma" or "the Company"), a leading Canadian producer of hot and cold rolled steel sheet and plate products, announced today that the Company will release its 2025 second quarter financial results after the market closes on Tuesday, July 29, 2025. A webcast and conference call will be held on Wednesday, July 30, 2025 at 11:00 a.m. Eastern Time to review the Company's results, discuss recent events, and conduct a question-and-answer session. The Company also provided guidance for its quarter ended June 30, 2025. Unless otherwise specified, all amounts are in Canadian Dollars.
Total steel shipments for the quarter are expected to be approximately 472,000 tons and Adjusted EBITDA is expected to be in the range of ($30) million to ($35) million.
Michael Garcia, Chief Executive Officer of Algoma, commented, "Our results for the quarter were in line with our expectations, with particular strength once again in our plate business. Macroeconomic uncertainties and tariff policy continue to impact our sector, but with first arc and first steel production from unit one of our electric arc furnace project achieved in the last few days, we are forging ahead with our transformation into what is expected to be one of North America's greenest producers of steel."
The live webcast and archived replay of the conference call can be accessed on the Investors section of the Company's website at <a href="http://www.ir.algoma.com/">www.ir.algoma.com</a>. For those unable to access the webcast, the conference call will be accessible domestically or internationally by dialing 877-425-9470 or 201-389-0878, respectively. Upon dialing in, please request to join the Algoma Steel Second Quarter Conference Call. To access the replay of the call, dial 844-512-2921 (domestic) or 412-317-6671 (international) with passcode 13754580.

ASTL

TSX:ASTL

Algoma Steel Group Provides Guidance For Its Quarter Ended June 30, 2025; Total Steel Shipments For The Quarter Are Expected To Be ~ 472,000 Tons And Adjusted EBITDA Is Expected To Be In The Range Of $30M To $35M

Press Releases

Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Gossamer Bio to Present Preclinical Data at the American Thoracic Society (ATS) 2025 International Conference

Gossamer Bio to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15, 2025

Gossamer Bio Announces First Quarter 2025 Financial Results and Provides Business Update, Including Closure of New Patient Screening in Phase 3 PROSERA Study

Comments

Gossamer Bio

Gossamer Bio (GOSS) Opciones

Gossamer Bio (NASDAQ:GOSS) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL